CNASHighly Regulated (List I)TranslatedPARKINANE LP
UNION PHARMACEUTIQUE CONSTANTINOISE
Identification
- Active ingredient (INN)
- TRIHEXYPHENIDYLE CHLORHYDRATE
- Internal code
- 15 D 034
- Country of Origin
- Algeria
- Pharmaceutical form
- Extended-release Capsule
- Prescription List
- Highly Regulated (List I)
- Packaging
- boite de 20
CNASDAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Associated Conditions
Lactation Dementia Pregnancy Renal impairment
Newborn exposed in utero to the medicine Obstruction of the urinary tract Intestinal obstruction Elderly Anti-cholinergic antiparkinsonian treatment in progress.
Mechanism of Action
Mechanism of action
Trihexyphenidyl is an anti-parkinsonian with central and peripheral anticholinergic action.
It blurs tremor and hypertonia, but has little effect on akinesia.
Adverse Effects
Rash Eye hypertonia Accommodation disorder Parotiditis Oral dryness Feeling dizzy Parotiditis suppurated Mental confusion Hallucination Agitation Tachycardia Paralytic ileus Constipation Colon dilation Memory Disorder Somnolence Atropinic effect Urinary retention Dysuria.